3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
1
Interventions
mirvetuximab soravtansine
2
Paclitaxel
2
sacituzumab govitecan
1
pembrolizumab
1
liposomal doxorubicin
1
Topotecan
1
Saline Solution
1
Glucose
1
Docetaxel
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Ovarian Epithelial
×
Octreotide
×
Clear all
No trials found.